Stock & Company Details
Cadrenal Therapeutics Inc $CVKD
Price:
N/A
N/A
3.6M
$5.6M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.27
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
CVKD technical indicators
Latest Cadrenal Therapeutics Inc (CVKD) indicator readings as of 2026-08-28.
CVKD's 14-day RSI is 26.6, in oversold territory. At $1.54 it is trading 73.2% below its 200-day moving average of $5.74, and below its 50-day average of $2.30. Price sits near the lower Bollinger Band ($1.42 to $2.11). ADX reads 31.4, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.
Finance Bot
Ask your questions
Start by typing a question below.
